Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Using a closed-loop system significantly improves time in range (TIR) 70-180 mg/dL in patients with type 1 diabetes (T1D). In a 6-month RCT, 112 subjects were randomly assigned to closed-loop control (Tandem Control-IQ) after obtaining 2 weeks of baseline Continuous glucose monitoring (CGM) data from sensor-augmented pump therapy. We compared glycemic outcomes from baseline to end of study among subgroups classified by baseline HbA1c levels. All HbA1c subgroups showed an improvement in TIR due to reduction of both hyperglycemia and hypoglycemia. Those with HbA1c <6.5% improved mostly by reducing nocturnal hypoglycemia due to the automated basal insulin adjustments. Those with HbA1c ≥8.5% improved mostly by reducing daytime and nocturnal hyperglycemia due to both automated basal insulin adjustments and correction boluses during the day. There does not appear to be any reason to exclude individuals with T1D from automated insulin delivery based on their HbA1c. Clinical Trial Identifier: NCT03563313.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353995 | PMC |
| http://dx.doi.org/10.1089/dia.2021.0524 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of sleep disturbances on health-related quality of life in postmenopausal women: a systematic review.
Menopause
September 2025
Bayer Consumer Care, Basel, Switzerland.
Importance: Sleep disturbances are common during and after the menopause transition, with potential effects on morbidity and quality of life; however, they may be underdiagnosed and undertreated.
Objective: We carried out a systematic literature review to investigate the prevalence and impact of sleep disturbances associated with menopause on women's health-related quality of life across the stages of menopause.
Evidence Review: Searches were conducted in PubMed and Excerpta Medica Database to identify articles published between 2013 and 2023 containing evidence for the impact of sleep quality on health-related quality of life and the epidemiology of sleep disturbances in women in menopause.
Cardiovascular benefits of liraglutide in patients with type 2 diabetes: an in-depth exploration.
Minerva Cardiol Angiol
September 2025
Department of Pharmacology, MGM Medical College and Hospital, MGM Institute of Health Sciences, Nerul, Navi Mumbai, India.
Liraglutide is a key therapeutic agent in managing type 2 diabetes mellitus (T2DM), with benefits extending beyond glycemic control to address cardiovascular and renal comorbidities. As T2DM prevalence rises globally, the need for medications that provide comprehensive health benefits becomes increasingly important. Liraglutide, a GLP-1 receptor agonist, has demonstrated effectiveness in reducing cardiovascular events, especially among patients with high cardiovascular risk, such as those with a prior history of myocardial infarction or stroke.
View Article and Find Full Text PDFPreoperative GLP-1 Receptor Agonist Use and Postoperative Outcomes Following Operative Ankle Fracture Repair in Patients With Type 2 Diabetes: A National Database Study.
Foot Ankle Int
September 2025
Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used in management of type 2 diabetes mellitus (T2DM) and obesity. Beyond glycemic control, these agents may influence orthopaedic outcomes. This study aimed to assess the relationship between preoperative GLP-1 RA use and postoperative complications in T2DM patients undergoing operative ankle fracture repair.
View Article and Find Full Text PDFEffects of transtheoretical model-based cognitive load dietary education on glycemic control and pregnancy outcomes in gestational diabetes mellitus: A retrospective propensity score-matched study.
Medicine (Baltimore)
September 2025
Department of Obstetrics, Nantong University Affiliated Maternal and Child Health Hospital, Nantong, Jiangsu, China.
This study aimed to evaluate the association between a dietary education approach grounded in the transtheoretical model and cognitive load theory and glycemic control and pregnancy-related outcomes in patients diagnosed with gestational diabetes mellitus (GDM). A retrospective analysis was performed using clinical data from 126 pregnant women with GDM who received care at our hospital between September 2021 and September 2023. Participants were grouped based on the type of nursing intervention received: a control group that underwent standard care and an observation group that received an additional cognitive load-informed dietary education program based on transtheoretical model.
View Article and Find Full Text PDFEfficacy and safety of survodutide on glycemic control and weight loss in adults: A systematic review and meta-analysis.
Diabetes Obes Metab
September 2025
Department of Infectious Diseases, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Aim: This meta-analysis aimed to evaluate the efficacy and safety of survodutide on glycemic control and weight loss in adults.
Methods: We systematically searched PubMed, Embase, the Cochrane Library, Scopus, Web of Science, and ClinicalTrials.gov for randomized controlled trials (RCTs) evaluating the efficacy and safety of survodutide up to 12 July 2025.